What modifiable risk factors exist for bipolar disorder in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Modifiable Risk Factors for Bipolar Disorder

Yes, several modifiable lifestyle and behavioral factors significantly influence both the risk of developing bipolar disorder and its clinical outcomes, with tobacco smoking emerging as a causal factor and physical activity, sleep disturbance, and substance use showing strong bidirectional relationships with the disorder. 1

Established Modifiable Risk Factors with Causal Evidence

Tobacco Smoking

  • Emerging evidence identifies tobacco smoking as a causal factor in the onset of bipolar disorder, not merely a consequence of the illness. 1
  • Cigarette smoking prevalence reaches 45% among people with bipolar disorder compared to general population rates, contributing to the 12-14 year reduction in life expectancy. 2

Physical Activity and Sedentary Behavior

  • Physical inactivity shows convergent evidence as both a risk factor for developing bipolar disorder and a modifiable target for primary prevention and clinical treatment. 1
  • Physical activity interventions demonstrate effectiveness in reducing cardiovascular risk and improving mental health outcomes in people with severe mental disorders including bipolar disorder. 1

Sleep Disturbance

  • A complex bidirectional relationship exists between sleep and bipolar disorder, with sleep disturbances significantly heightening the risk of suicidal behavior and potentially triggering mood episodes. 1
  • People with bipolar disorder take longer to fall asleep, have poorer-quality and shorter sleep, and wake more during the night compared to the general population. 1
  • Decreased need for sleep is both a cardinal symptom of mania and a potential trigger for episode onset. 3

Substance Use as Modifiable Risk Factors

Cannabis and Other Substances

  • Cannabis use, cocaine, and other substances (opioids, tranquilizers, stimulants, sedatives) show evidence as risk factors for developing bipolar disorder in longitudinal studies. 4
  • Substance use disorders are markedly prevalent in adolescents with bipolar disorder and should be targeted for intervention. 5
  • Rates of substance abuse are particularly high in this population, making substance use cessation a critical modifiable target. 5

Alcohol Consumption

  • Excessive alcohol consumption represents one of seven key cardiovascular risk behaviors that also influence mental health outcomes in bipolar disorder. 1

Dietary and Metabolic Factors

Diet and Nutrition

  • Poor dietary patterns show emerging associations with mental illness risk, though more research is needed to clearly identify the relationship between specific dietary patterns and bipolar disorder risk. 1
  • Metabolic syndrome (37% prevalence), obesity (21%), and type 2 diabetes (14%) are substantially elevated in bipolar disorder populations, representing modifiable targets. 2

Weight Management

  • Obesity shows suggestive evidence as a risk factor for bipolar disorder and may affect mental health through downstream inflammatory processes. 6
  • Weight gain associated with mood stabilizers and antipsychotics creates a modifiable risk factor requiring behavioral intervention. 1

Psychosocial and Environmental Modifiable Factors

Social Participation

  • Poor social participation is highly prevalent, with only 32.7% employment rate among people with bipolar disorder compared to 62.5% in the general population. 1
  • 82.8% of people with severe mental disorders avoid social interactions due to anxiety, and 80.1% perceive themselves as lonely. 1
  • Improving social participation represents a modifiable behavioral target for reducing cardiovascular and mental health risks. 1

Childhood Adversity and Trauma

  • Childhood adversity is supported by highly suggestive evidence as a risk factor for bipolar disorder. 6
  • Parental loss, adversities, abuse, and brain injury cluster as physical/psychological stress risk factors in longitudinal studies. 4
  • While past trauma cannot be modified, addressing ongoing trauma exposure and implementing trauma-informed care represents a modifiable intervention approach. 4

Medication Adherence as a Modifiable Factor

  • Poor medication adherence is a critical modifiable risk factor, with more than 50% of patients with bipolar disorder not adherent to treatment. 2
  • Medication adherence is particularly challenging given metabolic adverse effects of mood stabilizers and antipsychotics, but remains essential for managing medical comorbidities. 1
  • Behavioral interventions targeting medication adherence represent a key modifiable factor for improving outcomes. 1

Clinical Implications for Risk Modification

Primary Prevention Targets

  • For high-risk youth (offspring of parents with bipolar disorder), early intervention targeting sleep regulation, physical activity, and substance avoidance may delay or prevent episode onset. 7
  • Mindfulness-Based Cognitive Therapy for Children (MBCT-C), Interpersonal and Social Rhythm Therapy for Adolescents (IPSRT-A), or RUSH interventions target modifiable risk factors in asymptomatic high-risk youth. 7

Secondary Prevention Priorities

  • Addressing tobacco smoking cessation, physical activity promotion, sleep hygiene, substance use treatment, and medication adherence simultaneously offers the strongest evidence-based approach to modifying risk and improving outcomes. 1
  • Behavioral interventions addressing all seven cardiovascular risk behaviors (smoking, alcohol, diet, physical inactivity, sleep, social participation, medication adherence) show effectiveness in people with bipolar disorder. 1

Important Caveats

  • Individual environmental risk factors often show small attributable risk and are not specific to bipolar disorder, also associating with other mental illnesses. 8
  • Most identified risk factors lack established sensitivity, specificity, and predictive value due to heterogeneous study designs. 4
  • Gene-environment interactions likely play crucial roles, with environmental factors interacting with genetic vulnerability rather than acting independently. 8
  • The neurobiological pathways through which lifestyle factors affect bipolar disorder risk remain incompletely characterized, with inflammatory processes and gut microbiome representing promising research directions. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Bipolar Disorder During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Criteria for Bipolar Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Genetic Risk Factors in Bipolar Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Epidemiology and risk factors for bipolar disorder.

Therapeutic advances in psychopharmacology, 2018

Related Questions

What is a suitable PRN (as-needed) medication for anxiety in a patient with bipolar 1 disorder, currently taking Abilify (aripiprazole) and lithium, who experiences sedation with hydroxyzine?
What medication adjustments are appropriate for an 18-year-old female with bipolar disorder and Attention Deficit Hyperactivity Disorder (ADHD) currently on Abilify (aripiprazole) 5mg and Lamictal (lamotrigine) 50mg per day, experiencing ongoing anxiety and difficulty focusing?
What is the most likely underlying mechanism of this patient's condition, who presents with slurred speech, coarse tremor, and ataxic gait, with a history of bipolar disorder managed with lithium (lithium carbonate) and ziprasidone, and borderline hypertension managed with amlodipine, and currently experiencing severe nausea, vomiting, and diarrhea?
What is the first-line treatment for bipolar schizoaffective disorder?
How should I monitor and adjust therapy for a 14‑year‑old male with bipolar disorder who has failed aripiprazole and lurasidone, is now receiving paliperidone (Invega) 6 mg daily and valproic acid 500 mg at bedtime with a valproic acid trough level planned on day 6?
What are the primary and secondary transmission routes of hepatitis B virus and the recommended prevention measures?
How should I manage hypertriglyceridemia?
What is the recommended evaluation and management for a patient with hyperhomocysteinemia?
In a type 2 diabetic with HbA1c 6.7% (fasting glucose 7.2 mmol/L) on twice‑daily gliclazide, sitagliptin, atorvastatin and febuxostat, and eGFR (estimated glomerular filtration rate) ≥45 mL/min/1.73 m², can I reduce gliclazide to once daily and add dapagliflozin 10 mg once daily in the morning?
How should a patient with symptomatic grade 5 carotid atherosclerotic stenosis (≈70‑90% occlusion) following an acute stroke be managed?
How should I manage a patient with an acute embolic stroke secondary to a high‑risk (grade 5) aortic arch atheroma?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.